Doctors SLAM Kourtney Kardashian’s ‘Dangerous’ New Weight-Loss Pills as a Total 'Fad'

Kourtney Kardashian Barker's supplement brand, Lemme, has faced significant scrutiny and criticism for a range of its products, particularly an 'Ozempic-style' weight-loss pill, cellulite reduction capsules, and vagina health gummies. The brand, launched in September 2022, has been accused by fans and medical professionals alike of making unproven claims and capitalizing on body image insecurities, despite Kourtney's long-standing reputation as the most health-conscious Kar-Jenner sister.
The latest controversy centers around Lemme's GLP-1 Daily, a supplement marketed as an 'Ozempic-style' weight-loss aid. This product emerged amidst years of speculation that the Kar-Jenner sisters use Ozempic, a diabetes drug that gained prominence for weight loss. Ozempic contains a synthetic version of the GLP-1 hormone, which slows digestion and dulls hunger, leading to weight loss. Lemme's GLP-1 Daily, however, does not contain the key ingredient found in Ozempic (semaglutide). Instead, it claims to naturally increase GLP-1 levels using lemon and saffron extracts, with marketing suggesting it can 'reduce body weight, visceral fat, and hip and waist circumference' and offer 'a GLP-1 solution without the side effects' of the injectable drug. This claim has been widely dismissed by experts, including plastic surgeon Naveen Cavale, who stated, 'While the supplement may be marketed as a natural alternative, it doesn’t offer the same scientifically proven impact as injectable medications like Ozempic.' He further warned that such products create false hope and can lead to frustration and worsened body image issues. Fans also criticized the £69 one-time purchase price, calling it a 'facade' and 'false marketing.'
Another product, Lemme Smooth, designed to 'combat cellulite from the inside out' and reduce cellulite in just 28 days, also drew heavy fire. This daily tablet, formulated with French Cantaloupe Melon (SOD B Dimpless), an antioxidant, was deemed a 'fad' and an 'ineffective solution to a perfectly normal condition' by Mr. Naveen Cavale. He emphasized that cellulite is a common and natural skin condition for the majority of women and that these pills 'lack scientific backing and have not demonstrated significant, long-lasting results in clinical trials.' Both the GLP-1 Daily and Lemme Smooth carry disclaimers stating, 'This product is not intended to diagnose, treat, cure or prevent any disease,' and that their claims 'have not been evaluated by the Food and Drug Administration (FDA).' The FDA ensures the safety, efficacy, and security of drugs, vitamins, supplements, and medical devices, providing consumers with assurance that approved products have been thoroughly tested.
Lemme also faced significant backlash in February of last year for its Lemme Purr vagina gummies, which were marketed to boost vaginal health and alter its taste using pineapple, Vitamin C, and probiotics. Dr. Jen Gunter, a gynecologist and author of 'The Vagina Bible,' vehemently criticized the product, stating, 'Anyone who suggests that your vagina isn't fresh or needs an improved taste is a misogynist and awful person. And yes, that includes you Kourtney Kardashian and your Lemme grift.' She also disputed the common belief that consuming pineapple affects the taste of bodily fluids.
Kourtney Kardashian founded Lemme with the stated aim of creating 'science-backed' vitamins and botanical supplements using 'clinically-backed ingredients and formulations.' Her interest in wellness reportedly stemmed from the birth of her eldest son, Mason Disick. However, the consistent pattern of expert and public criticism across multiple product lines suggests a significant disconnect between the brand's marketing and verifiable scientific evidence. Critics argue that these products exploit the societal pressure young women face to conform to unrealistic body standards, offering expensive, unproven 'quick-fix solutions' that may ultimately harm mental health rather than improve wellness.
You may also like...
When Sacred Calendars Align: What a Rare Religious Overlap Can Teach Us
As Lent, Ramadan, and the Lunar calendar converge in February 2026, this short piece explores religious tolerance, commu...
Arsenal Under Fire: Arteta Defiantly Rejects 'Bottlers' Label Amid Title Race Nerves!

Mikel Arteta vehemently denies accusations of Arsenal being "bottlers" following a stumble against Wolves, which handed ...
Sensational Transfer Buzz: Casemiro Linked with Messi or Ronaldo Reunion Post-Man Utd Exit!

The latest transfer window sees major shifts as Manchester United's Casemiro draws interest from Inter Miami and Al Nass...
WBD Deal Heats Up: Netflix Co-CEO Fights for Takeover Amid DOJ Approval Claims!

Netflix co-CEO Ted Sarandos is vigorously advocating for the company's $83 billion acquisition of Warner Bros. Discovery...
KPop Demon Hunters' Stars and Songwriters Celebrate Lunar New Year Success!

Brooks Brothers and Gold House celebrated Lunar New Year with a celebrity-filled dinner in Beverly Hills, featuring rema...
Life-Saving Breakthrough: New US-Backed HIV Injection to Reach Thousands in Zimbabwe

The United States is backing a new twice-yearly HIV prevention injection, lenacapavir (LEN), for 271,000 people in Zimba...
OpenAI's Moral Crossroads: Nearly Tipped Off Police About School Shooter Threat Months Ago
ChatGPT-maker OpenAI disclosed it had identified Jesse Van Rootselaar's account for violent activities last year, prior ...
MTN Nigeria's Market Soars: Stock Hits Record High Post $6.2B Deal
MTN Nigeria's shares surged to a record high following MTN Group's $6.2 billion acquisition of IHS Towers. This strategi...
:max_bytes(150000):strip_icc()/Health-GettyImages-2227107996-ea68ba3036d747d79ad338826a497f9b.jpg)


